CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on enhancing drug discovery through the integration of 3D printed continuous flow reactors and immobilized enzymes. By improving enzyme stability and recyclability, it aims to streamline biocatalysis processes, making them more efficient and sustainable for the pharmaceutical industry.
Within Industrial Biotechnology, applied biocatalysis is poised to transform drug discovery and development by pharmaceutical industry.
Enzymes as catalysts, allow for synthetic chemists to generate molecular complexity avoiding costly and time-consuming protection and deprotection steps.
However, the high cost associated to their use, especially if a co-factor is required, the low substrate tolerance and productivity and the difficulties for scale-up, strongly limit the industrial uptake of the…
UNIVERSITAT JAUME I DE CASTELLON
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
